Cargando…
DT389-YP7, a Recombinant Immunotoxin against Glypican-3 That Inhibits Hepatocellular Cancer Cells: An In Vitro Study
Hepatocellular carcinoma (HCC) is one of the high-metastatic types of cancer, and metastasis occurs in one-third of patients with HCC. To maintain the effectiveness of drug compounds on cancer cells and minimize their side effects on normal cells, it is important to use new approaches for overcoming...
Autores principales: | Hashemi Yeganeh, Hamid, Heiat, Mohammad, Kieliszek, Marek, Alavian, Seyed Moayed, Rezaie, Ehsan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617615/ https://www.ncbi.nlm.nih.gov/pubmed/34822533 http://dx.doi.org/10.3390/toxins13110749 |
Ejemplares similares
-
Immunotoxins Immunotherapy against Hepatocellular Carcinoma: A Promising Prospect
por: Heiat, Mohammad, et al.
Publicado: (2021) -
Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer
por: Fleming, Bryan D., et al.
Publicado: (2016) -
Development of Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer: An Update
por: Fleming, Bryan D., et al.
Publicado: (2020) -
Classical and Modern Approaches Used for Viral Hepatitis Diagnosis
por: Heiat, Mohammad, et al.
Publicado: (2014) -
Concomitant use of heat-shock protein 70, glutamine synthetase and glypican-3 is useful in diagnosis of HBV-related hepatocellular carcinoma with higher specificity and sensitivity
por: Moudi, Bita, et al.
Publicado: (2018)